カテゴリー： Market Monitor Global, 世界, 医療/バイオ

セマグルチドの世界市場見通し2023年-2029年

◆英語タイトル：Semaglutide Market, Global Outlook and Forecast 2023-2029
	◆商品コード：MMG23LY8654 ◆発行会社（リサーチ会社）：Market Monitor Global ◆発行日：2023年7月 ◆ページ数：78 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後2-3営業日） ◆調査対象地域：グローバル ◆産業分野：医薬品＆ヘルスケア

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Semaglutide Market 調査レポートは次の情報を含め、グローバルにおけるのセマグルチド市場規模と予測を収録しています。・世界のセマグルチド市場：売上、2018年-2023年、2024年-2029年
・世界のセマグルチド市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のセマグルチド市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「注射」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

セマグルチドのグローバル主要企業は、Novo Nordiskなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、セマグルチドのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界のセマグルチド市場：タイプ別、2018年-2023年、2024年-2029年
世界のセマグルチド市場：タイプ別市場シェア、2022年
・注射、経口

世界のセマグルチド市場：用途別、2018年-2023年、2024年-2029年
世界のセマグルチド市場：用途別市場シェア、2022年
・病院、診療所

世界のセマグルチド市場：地域・国別、2018年-2023年、2024年-2029年
世界のセマグルチド市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業におけるセマグルチドのグローバル売上、2018年-2023年
・主要企業におけるセマグルチドのグローバル売上シェア、2022年
・主要企業におけるセマグルチドのグローバル販売量、2018年-2023年
・主要企業におけるセマグルチドのグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Novo Nordisk

*************************************************************

・調査・分析レポートの概要
セマグルチド市場の定義
市場セグメント
世界のセマグルチド市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のセマグルチド市場規模
世界のセマグルチド市場規模：2022年 VS 2029年
世界のセマグルチド市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのセマグルチドの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のセマグルチド製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：注射、経口
セマグルチドのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、診療所
セマグルチドの用途別グローバル売上・予測

・地域別市場分析
地域別セマグルチド市場規模 2022年と2029年
地域別セマグルチド売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Novo Nordisk
...

Semaglutide (trade names Rybelsus, Ozempic) is a medication for the treatment of type 2 diabetes. Side effects include medullary thyroid cancer, kidney problems, diabetic retinopathy, allergic reactions, low blood sugar, and pancreatitis. Semaglutide acts like human glucagon-like peptide-1 (GLP-1) so that it increases insulin secretion, thereby increasing sugar metabolism. It is distributed as a metered subcutaneous injection in a prefilled pen. One of its advantages over other antidiabetic drugs is that it has a long duration of action, thus, only once-a-week injection is sufficient. An injection version was approved in 2017 in the United States, and in Europe, Canada, and Japan in 2018. An version which is taken by mouth was approved in 2019 in the United States. It is the first glucagon-like peptide (GLP-1) receptor protein treatment approved for use in the United States that does not need to be injected. It was developed by the Danish company Novo Nordisk.
This report aims to provide a comprehensive presentation of the global market for Semaglutide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Semaglutide. This report contains market size and forecasts of Semaglutide in global, including the following market information:
Global Semaglutide Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Semaglutide Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Semaglutide companies in 2022 (%)
The global Semaglutide market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Injection Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Semaglutide include Novo Nordisk. etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Semaglutide manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Semaglutide Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Semaglutide Market Segment Percentages, by Type, 2022 (%)
Injection
Oral
Global Semaglutide Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Semaglutide Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinic
Global Semaglutide Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Semaglutide Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Semaglutide revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Semaglutide revenues share in global market, 2022 (%)
Key companies Semaglutide sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Semaglutide sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novo Nordisk
Outline of Major Chapters:
Chapter 1: Introduces the definition of Semaglutide, market overview.
Chapter 2: Global Semaglutide market size in revenue and volume.
Chapter 3: Detailed analysis of Semaglutide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Semaglutide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Semaglutide capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Semaglutide Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Semaglutide Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Semaglutide Overall Market Size
2.1 Global Semaglutide Market Size: 2022 VS 2029
2.2 Global Semaglutide Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Semaglutide Sales: 2018-2029
3 Company Landscape
3.1 Top Semaglutide Players in Global Market
3.2 Top Global Semaglutide Companies Ranked by Revenue
3.3 Global Semaglutide Revenue by Companies
3.4 Global Semaglutide Sales by Companies
3.5 Global Semaglutide Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Semaglutide Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Semaglutide Product Type
3.8 Tier 1, Tier 2 and Tier 3 Semaglutide Players in Global Market
3.8.1 List of Global Tier 1 Semaglutide Companies
3.8.2 List of Global Tier 2 and Tier 3 Semaglutide Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Semaglutide Market Size Markets, 2022 & 2029
4.1.2 Injection
4.1.3 Oral
4.2 By Type – Global Semaglutide Revenue & Forecasts
4.2.1 By Type – Global Semaglutide Revenue, 2018-2023
4.2.2 By Type – Global Semaglutide Revenue, 2024-2029
4.2.3 By Type – Global Semaglutide Revenue Market Share, 2018-2029
4.3 By Type – Global Semaglutide Sales & Forecasts
4.3.1 By Type – Global Semaglutide Sales, 2018-2023
4.3.2 By Type – Global Semaglutide Sales, 2024-2029
4.3.3 By Type – Global Semaglutide Sales Market Share, 2018-2029
4.4 By Type – Global Semaglutide Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Semaglutide Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.2 By Application – Global Semaglutide Revenue & Forecasts
5.2.1 By Application – Global Semaglutide Revenue, 2018-2023
5.2.2 By Application – Global Semaglutide Revenue, 2024-2029
5.2.3 By Application – Global Semaglutide Revenue Market Share, 2018-2029
5.3 By Application – Global Semaglutide Sales & Forecasts
5.3.1 By Application – Global Semaglutide Sales, 2018-2023
5.3.2 By Application – Global Semaglutide Sales, 2024-2029
5.3.3 By Application – Global Semaglutide Sales Market Share, 2018-2029
5.4 By Application – Global Semaglutide Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Semaglutide Market Size, 2022 & 2029
6.2 By Region – Global Semaglutide Revenue & Forecasts
6.2.1 By Region – Global Semaglutide Revenue, 2018-2023
6.2.2 By Region – Global Semaglutide Revenue, 2024-2029
6.2.3 By Region – Global Semaglutide Revenue Market Share, 2018-2029
6.3 By Region – Global Semaglutide Sales & Forecasts
6.3.1 By Region – Global Semaglutide Sales, 2018-2023
6.3.2 By Region – Global Semaglutide Sales, 2024-2029
6.3.3 By Region – Global Semaglutide Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Semaglutide Revenue, 2018-2029
6.4.2 By Country – North America Semaglutide Sales, 2018-2029
6.4.3 US Semaglutide Market Size, 2018-2029
6.4.4 Canada Semaglutide Market Size, 2018-2029
6.4.5 Mexico Semaglutide Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Semaglutide Revenue, 2018-2029
6.5.2 By Country – Europe Semaglutide Sales, 2018-2029
6.5.3 Germany Semaglutide Market Size, 2018-2029
6.5.4 France Semaglutide Market Size, 2018-2029
6.5.5 U.K. Semaglutide Market Size, 2018-2029
6.5.6 Italy Semaglutide Market Size, 2018-2029
6.5.7 Russia Semaglutide Market Size, 2018-2029
6.5.8 Nordic Countries Semaglutide Market Size, 2018-2029
6.5.9 Benelux Semaglutide Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Semaglutide Revenue, 2018-2029
6.6.2 By Region – Asia Semaglutide Sales, 2018-2029
6.6.3 China Semaglutide Market Size, 2018-2029
6.6.4 Japan Semaglutide Market Size, 2018-2029
6.6.5 South Korea Semaglutide Market Size, 2018-2029
6.6.6 Southeast Asia Semaglutide Market Size, 2018-2029
6.6.7 India Semaglutide Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Semaglutide Revenue, 2018-2029
6.7.2 By Country – South America Semaglutide Sales, 2018-2029
6.7.3 Brazil Semaglutide Market Size, 2018-2029
6.7.4 Argentina Semaglutide Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Semaglutide Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Semaglutide Sales, 2018-2029
6.8.3 Turkey Semaglutide Market Size, 2018-2029
6.8.4 Israel Semaglutide Market Size, 2018-2029
6.8.5 Saudi Arabia Semaglutide Market Size, 2018-2029
6.8.6 UAE Semaglutide Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Novo Nordisk
7.1.1 Novo Nordisk Company Summary
7.1.2 Novo Nordisk Business Overview
7.1.3 Novo Nordisk Semaglutide Major Product Offerings
7.1.4 Novo Nordisk Semaglutide Sales and Revenue in Global (2018-2023)
7.1.5 Novo Nordisk Key News & Latest Developments
8 Global Semaglutide Production Capacity, Analysis
8.1 Global Semaglutide Production Capacity, 2018-2029
8.2 Semaglutide Production Capacity of Key Manufacturers in Global Market
8.3 Global Semaglutide Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Semaglutide Supply Chain Analysis
10.1 Semaglutide Industry Value Chain
10.2 Semaglutide Upstream Market
10.3 Semaglutide Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Semaglutide Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Semaglutide in Global Market
Table 2. Top Semaglutide Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Semaglutide Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Semaglutide Revenue Share by Companies, 2018-2023
Table 5. Global Semaglutide Sales by Companies, (K Units), 2018-2023
Table 6. Global Semaglutide Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Semaglutide Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Semaglutide Product Type
Table 9. List of Global Tier 1 Semaglutide Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Semaglutide Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Semaglutide Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Semaglutide Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Semaglutide Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Semaglutide Sales (K Units), 2018-2023
Table 15. By Type - Global Semaglutide Sales (K Units), 2024-2029
Table 16. By Application – Global Semaglutide Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Semaglutide Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Semaglutide Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Semaglutide Sales (K Units), 2018-2023
Table 20. By Application - Global Semaglutide Sales (K Units), 2024-2029
Table 21. By Region – Global Semaglutide Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Semaglutide Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Semaglutide Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Semaglutide Sales (K Units), 2018-2023
Table 25. By Region - Global Semaglutide Sales (K Units), 2024-2029
Table 26. By Country - North America Semaglutide Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Semaglutide Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Semaglutide Sales, (K Units), 2018-2023
Table 29. By Country - North America Semaglutide Sales, (K Units), 2024-2029
Table 30. By Country - Europe Semaglutide Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Semaglutide Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Semaglutide Sales, (K Units), 2018-2023
Table 33. By Country - Europe Semaglutide Sales, (K Units), 2024-2029
Table 34. By Region - Asia Semaglutide Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Semaglutide Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Semaglutide Sales, (K Units), 2018-2023
Table 37. By Region - Asia Semaglutide Sales, (K Units), 2024-2029
Table 38. By Country - South America Semaglutide Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Semaglutide Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Semaglutide Sales, (K Units), 2018-2023
Table 41. By Country - South America Semaglutide Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Semaglutide Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Semaglutide Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Semaglutide Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Semaglutide Sales, (K Units), 2024-2029
Table 46. Novo Nordisk Company Summary
Table 47. Novo Nordisk Semaglutide Product Offerings
Table 48. Novo Nordisk Semaglutide Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Novo Nordisk Key News & Latest Developments
Table 50. Semaglutide Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 51. Global Semaglutide Capacity Market Share of Key Manufacturers, 2021-2023
Table 52. Global Semaglutide Production by Region, 2018-2023 (K Units)
Table 53. Global Semaglutide Production by Region, 2024-2029 (K Units)
Table 54. Semaglutide Market Opportunities & Trends in Global Market
Table 55. Semaglutide Market Drivers in Global Market
Table 56. Semaglutide Market Restraints in Global Market
Table 57. Semaglutide Raw Materials
Table 58. Semaglutide Raw Materials Suppliers in Global Market
Table 59. Typical Semaglutide Downstream
Table 60. Semaglutide Downstream Clients in Global Market
Table 61. Semaglutide Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Semaglutide Segment by Type in 2022
Figure 2. Semaglutide Segment by Application in 2022
Figure 3. Global Semaglutide Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Semaglutide Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Semaglutide Revenue, 2018-2029 (US$, Mn)
Figure 7. Semaglutide Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Semaglutide Revenue in 2022
Figure 9. By Type - Global Semaglutide Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Semaglutide Revenue Market Share, 2018-2029
Figure 11. By Type - Global Semaglutide Sales Market Share, 2018-2029
Figure 12. By Type - Global Semaglutide Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Semaglutide Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Semaglutide Revenue Market Share, 2018-2029
Figure 15. By Application - Global Semaglutide Sales Market Share, 2018-2029
Figure 16. By Application - Global Semaglutide Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Semaglutide Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Semaglutide Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Semaglutide Revenue Market Share, 2018-2029
Figure 20. By Region - Global Semaglutide Sales Market Share, 2018-2029
Figure 21. By Country - North America Semaglutide Revenue Market Share, 2018-2029
Figure 22. By Country - North America Semaglutide Sales Market Share, 2018-2029
Figure 23. US Semaglutide Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Semaglutide Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Semaglutide Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Semaglutide Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Semaglutide Sales Market Share, 2018-2029
Figure 28. Germany Semaglutide Revenue, (US$, Mn), 2018-2029
Figure 29. France Semaglutide Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Semaglutide Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Semaglutide Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Semaglutide Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Semaglutide Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Semaglutide Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Semaglutide Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Semaglutide Sales Market Share, 2018-2029
Figure 37. China Semaglutide Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Semaglutide Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Semaglutide Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Semaglutide Revenue, (US$, Mn), 2018-2029
Figure 41. India Semaglutide Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Semaglutide Revenue Market Share, 2018-2029
Figure 43. By Country - South America Semaglutide Sales Market Share, 2018-2029
Figure 44. Brazil Semaglutide Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Semaglutide Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Semaglutide Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Semaglutide Sales Market Share, 2018-2029
Figure 48. Turkey Semaglutide Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Semaglutide Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Semaglutide Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Semaglutide Revenue, (US$, Mn), 2018-2029
Figure 52. Global Semaglutide Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Semaglutide by Region, 2022 VS 2029
Figure 54. Semaglutide Industry Value Chain
Figure 55. Marketing Channels

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ セマグルチドの世界市場見通し2023年-2029年(Semaglutide Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

セマグルチドの世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp